From: Survivin expression and its clinical significance in pancreatic cancer
No. of case | ||
---|---|---|
Age* | 59 (33–76) | |
M:F | 36:13 | |
Chief Complaint | Pain | 20(40.8%) |
Jaundice | 18(36.7%) | |
Indigestion | 6(12.2%) | |
Others | 5(10.1%) | |
Location | Head | 35(71.4%) |
Body | 1(2.0%) | |
Tail | 7(14.3%) | |
Body & Tail | 6(12.3%) | |
Stage | I | 8(16.3%) |
II | 26(53.1%) | |
III | 10(20.4%) | |
IV | 5(10.2%) | |
Adjuvant treatment | Yes | 20(40.8%) |
No | 14(28.6%) | |
Recurrence after curative surgery | 18/35+ |